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Objectives: Aortobifemoral graft (ABFG) infections presenting with
single-limb involvement can be managed with unilateral limb excision or
complete graft removal. This study aimed to identify factors predictive of
subsequent contralateral limb infection in patients initially undergoing uni-
lateral limb excision.
Methods: A retrospective review of patients treated for infected
ABFGs from 2001 to July 2014 was performed. Endovascular and aortic
tube graft infections were excluded. Primary outcomes were freedom
from contralateral graft limb excision, overall survival, and factors potentially
predictive of subsequent contralateral limb infection.
Results: Fifteen patients underwent unilateral graft limb excision
with retroperitoneal exploration of the affected ABFG limb and revascu-
larization for unilateral graft limb infection. Original indication for
placement of the ABFG was aortoiliac occlusive disease in 11 patients
and aneurysm in four. No patients had clinical or radiographic evidence
for contralateral limb infection at initial presentation. Seven patients, all
of whom underwent initial operation for aortoiliac occlusive disease
developed contralateral limb infection at a median follow-up of 23.2
months. The remaining eight patients had no evidence of contralateral
limb infection at median follow-up of 38.8 months. Patient demo-
graphics were similar between the two groups. Five of the seven patients
who developed contralateral limb infection had imaging evidence of ipsi-
lateral graft infection above the inguinal ligament at the time of initial
graft infection. Operative exploration during unilateral excision in this
group revealed a well-incorporated graft without extension to the bifur-
cation. There was no dominant organism cultured in either group, and
duration of targeted antibiotic therapy was similar in both groups ($6
weeks). For the series, there were no amputations, and overall mortality
was 40% with median follow-up of 44.7 months.
Conclusions: Unilateral infection of an ABFG can be managed with
single-limb excision; however, 50% of patients will return with contralateral
limb infection at a median of 2 years. Clinical assessment of graft incorpora-
tion lacks speciﬁcity and does not indicate freedom from contralateral limb
infection. Factors predicting contralateral involvement include initial opera-
tion for aortoiliac occlusive disease and initial imaging or operative ﬁndings
suspicious for infection above the inguinal ligament of the unilateral limb.
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Objectives: This study reviewed the outcomes of percutaneous endo-
vascular aortic repair (PEVAR) of complex aortic aneurysms using large-
diameter sheaths for thoracic, fenestrated, and branched stent grafts.
Methods: We reviewed the outcomes of all consecutive patients who
underwent PEVAR of descending thoracic (DTA), thoracoabdominal
(TAAA), pararenal (PRA) or aortoiliac aneurysms (AIAs) using large-diam-
eter sheaths for placement of thoracic, fenestrated, or branched stent grafts.
Patients treated by fenestrated and branched stent grafts were enrolled in pro-
spective physician-sponsored investigational device exemption protocols. A
percutaneous approach was selected in patients with <50% posterior, minimal
anterior, or no calciﬁcation in the common femoral artery using standardized
preclosure technique with two Perclose devices (Abbott Vascular Inc., Red-
wood City, Calif) in each femoral puncture site. End points were technical
success, conversion to open femoral artery repair, 30-day mortality and major
adverse events, and freedom from femoral access-site complications.
Results: There were 102 patients treated for 48 PRAs, 27 TAAAs, 19
DTAs, and 8 AIAs. A total of 171 femoral arteries were closed using preclo-
sure technique. Transfemoral sheath size was 18F in four vessels (3%), 20F
in 120 (70%), and $22F in 47 (27%). Eighty-three patients (81%) had
visceral branch incorporation, which required brachial artery access using
small incision in 48. Technical success for percutaneous transfemoral closurewas 95% (162 of 171). Nine intraoperative failures were managed by open
femoral conversion using primary repair in six, interposition graft in two,
and patch angioplasty in one. Mean estimated blood loss was 444 6 569
mL. There were no patients with uncontrolled puncture-related hemor-
rhage, retroperitoneal hematoma, or intra-operative hypotension. The 30-
day mortality was 0.9% (one of 101) and 30-day rate of major adverse events
was 15% (16 of 102). Spinal cord injury occurred in one patient (0.9%). Five
(3%) access-related complications occurred, including femoral artery occlu-
sion in three and hematoma or pseudoaneurysm in one each. Wound-
related complications occurred in one patient (0.5%) who required open
femoral artery conversion for exposure and repair. After a mean follow up
of 1-year, freedom from femoral access-site complication was 97% 6 2%.
Conclusions: PEVARusing thepreclosure technique is safe and effective
in select patients with complex aortic aneurysms who have minimal or no
femoral calciﬁcations and require large-diameter sheaths for thoracic, fenes-
trated, and branched stent grafts. Rate of puncture (3%) and wound-related
complications (0.5%) is low,andnouncontrolledpuncture-relatedhemorrhage,
retroperitoneal hematoma, or systemic hypotension occurred in this series.
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Objectives: Covering the left subclavian artery (LSA) during thoracic
endovascular aortic repair (TEVAR) for proximal seal is generally safe and
well tolerated. The purpose of this study was to determine if this practice
is safe in elderly patients.
Methods: The National Surgical Quality Improvement Program
(NSQIP) database was queried, from the years 2005 to 2011, to identify pa-
tients who underwent TEVAR. Octogenarians were separated into two
groups, one where the LSA was covered (C-SA) and another where it was
not covered (U-SA). Patient demographics, comorbidities, perioperative
data, and outcomes were compared.
Results: There were 392 patients aged >80 who underwent TEVAR,
128 patients in the C-SA group and 264 in the U-SA group. There was no
signiﬁcant difference in demographics or baseline cardiovascular or pulmo-
nary comorbidities between groups. There was also no difference in emer-
gency procedures between C-SA and U-SA groups (27% vs 21%; P ¼
.18). The C-SA group had signiﬁcantly more intraoperative cardiac arrest
(4% vs 1%; P ¼ .03) and signiﬁcantly more received intraoperative blood
transfusions (32% vs 21%; P ¼ .02). There was also a higher postoperative
rate of stroke (9% vs 3%; P ¼ .03) and sepsis (9% vs 3%; P < .01) in the
C-SA group compared with the U-SA group.
Conclusions: Covering the LSA in octogenarians is associated with
signiﬁcantly increased perioperative morbidity. We recommend caution
when considering coverage of the LCA during TEVAR. These patients
may beneﬁt from elective revascularization when possible.
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Objectives: Aortic dissection is a dynamic process that can extend
distal to the entry tear or proximally in a retrograde fashion. We sought
to determine associations for development of new acute type A aortic dissec-
tion (ATAD) after type B dissection (TBAD).
Methods: We reviewed our aortic dissection database for cases of
ATAD from 2002 to 2013 that had known TBAD. Imaging and intraoper-
ative reports were used to determine presence of entry tear with dissection
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ables were analyzed.
Results: Among 419 new cases of ATAD, we identiﬁed 16 patients
(3.8%) with previous known TBAD. Presence of ﬂap vs IMH could be
determined in 403 of 419 cases (96%). IMH was more common in pa-
tients with previous TBAD (56% vs 13%; P < .001). Previous thoracic
(six of 16 [38%]; P < .001) and abdominal aortic surgery (four of 16
[25%]; P ¼ .004) was also more common. There were two cases each
of open and endovascular repair of the descending thoracic aorta (Fig)
and two cases of open thoracoabdominal aortic repair. On multivariate
regression analysis, IMH and previous aortic surgery were associated
with new ATAD (P < .004). In-hospital mortality after ATAD repair in
TBAD patients occurred in one of 16 (6%).
Conclusions: Patients with IMH of the descending thoracic aorta
may develop new dissection in the ascending aorta. Not surprisingly, in pa-
tients with TBAD and new ATAD, there was an association with previous
aortic surgery. Surveillance of the ascending aorta is mandatory in all pa-
tients with TBAD.Fig. A new type A dissection in a patient initially treated with thoracic
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Objectives: Venous thoracic outlet syndrome (VTOS) most
commonly is treated by transaxillary, supraclavicular, or paraclavicular ap-
proaches based on surgeon preference. However, we have adopted an infra-
clavicular approach to VTOS because the surgical pathology is in the
anterior costoclavicular space. We hypothesize that this approach for
thoracic outlet decompression provides excellent access to the costoclavicu-
lar space and the axillosubclavian veins for safe and effective treatment of pa-
tients with an acute presentation of VTOS.
Methods: We retrospectively reviewed all consecutive patients who un-
derwent infraclavicular thoracic outlet decompression for an acute presentation
of VTOS from July 2005 to February 2014 by a single surgeon. Acute presen-
tation was deﬁned as <14 days between the onset of symptoms and catheter-
directedthrombolysis (CDT).Demographics, primary andsecondary subclavian
vein patency, perioperative outcomes, and reinterventions were recorded.
Results: Thirty patients (60% male) underwent an infraclavicular
approach for treatment of VTOS. Average age was 33 years. All patients un-
derwent CDT and subsequent infraclavicular ﬁrst rib resection and intrao-
perative venography, which was technically successful in all patients.
Intraoperative subclavian vein angioplasty was performed in 70%. Median
postoperative length of stay was 2 days (range, 2-6 days), blood loss was
75 mL (range, 20-200 mL), and operative time was 117 minutes (range,
76-166 minutes). Median follow-up was 78 days (range, 2-483 days). Ultra-
sound imaging at follow-up was performed in 24 of 30 (80%), with all pa-
tients having patent subclavian veins at last follow-up. Reinterventions
included two cases for rethrombosis and one case of hemothorax. There
were no complications of brachial plexus or phrenic nerve injury. All patients
at last follow-up were symptom free and subclavian veins were patent.Conclusions: An infraclavicular approach is a safe and effective treat-
ment for acute VTOS. It provides excellent access to the costoclavicular
space for ﬁrst rib resection and subclavian venolysis, while at the same
time minimizes the risk of brachial plexus and phrenic nerve injury.
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Objectives: The effects of concomitant endovascular interventions on
multiple infrapopliteal vessels are not well known, and the long-term
sequelae of such procedures have not been reported.
Methods: From 2004 to 2014, 673 patients underwent an infrapo-
pliteal endovascular intervention for tissue loss (77%), rest pain (13%),
stenosis of a previously treated vessel (5%), acute limb ischemia (3%),
or claudication (2%). Data collected included renal artery stenosis
(RAS) events (revascularization, major amputation, or stenosis [>3.5
step-up by duplex]) and wound healing. Patients without an initial indi-
cation of critical limb ischemia (CLI) were excluded. Patients were char-
acterized by single-vessel infrapopliteal interventions and multiple-vessel
infrapopliteal interventions. Worsened Rutherford class between index
procedure and failure was also noted.
Results: Of the 673 patients, 596 underwent an infrapopliteal endovas-
cular intervention for CLI: 85% for tissue loss and 15% for rest pain. During a
single procedure, 533 (89%) patients underwent a single-vessel intervention,
and 63 (11%) underwent a multiple-vessel intervention. Patients undergoing
a single-vessel intervention hadmore commonly experienced a prior ipsilateral
endovascular procedure (17% vs 10%; P¼ .04), whereas patients undergoing a
multiple-vessel interventionmore often suffered from diabetes (78% vs 89%; P
¼ .03) andweremore often discharged to a rehabilitation facility (33% vs 41%;
P¼ .04). Survival analysis revealed no difference in the proportion of patients
experiencing a restenosis (P ¼ .11). A Cox regression model illustrated that
long-term outcomes do not differ between patients undergoing a multiple-
vessel intervention vs those undergoing a single-vessel intervention. Among
the 596 patients, a RAS event occurred in 284 limbs (48%), and there was
no signiﬁcant difference in the rate of RAS events between single-vessel and
multiple-vessel infrapopliteal interventions (48% vs 49%; P ¼ .84; Fig). The
amputation rate also did not signiﬁcantly differ between the two groups
(14% vs 16%; P ¼ .71). In both groups, 8% of RAS patients presented with
a worse ischemia class compared with their initial symptoms.
Conclusions: Our data suggest that multiple-vessel intervention does
not improve outcomes compared with single-vessel intervention after any
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